EUCTR2018-003640-23-IT进行中(未招募)1 期
SE OF HEPATITIS C+ DONORS FOR SOLID ORGAN TRANSPLANTATION IN A GEOGRAPHICAL AREA WITH HCV+ ENDEMIC INFECTION AND WITH A LOW-RATE CADAVERIC ORGAN DONOR AVAILABILITY.A PHASE II OPEN, MONOCENTRIC CLINICAL STUDY. - DONORHEPAC
ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE - ISMETT0 个研究点目标入组 212 人开始时间: 2021年1月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 212
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) male or female recipient over 18 years of age.
- •2) negative candidate for HCV candidate and inserted in waiting list for solid organ transplant at IRCCS / ISMETT.
- •3) Female recipients potentially able to undertake a pregnancy who have committed themselves to ensure an effective practice of birth control during the first 6 months of study.
- •4) recipient affected by a terminal stage disease or oncological pathology, suitable candidate and included in waiting list for organ transplantation at IRCCS / ISMETT.
- •5) a patient who understands the purpose and risks of the study, who has been fully informed and has given written informed consent.
- •6) a patient unable to write and / or read, but who is fully capable of understanding the oral information proposed by the researcher (or the appointed representative) and who has given oral informed consent written in written form by an independent third person .
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 170
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 42
排除标准
- •1) patients with acute organ failure
- •2) pediatric patients or pediatric donor solid organ transplant candidates
- •3) patient in poor multi-organ clinical conditions
- •4) patient candidate for multi-organ transplantation
- •5) participant or who has participated in another clinical trial and / or who is taking or has taken an experimental drug in the last 30 days
- •6) patient with absolute improbability to respect the programmatic visits foreseen by the protocol
- •7) patient with any form of substance abuse, and / or carrier of psychiatric disorders or a condition that, in the opinion of the investigator, can invalidate the communication with the researcher himself.
- •8) patient over the age of 70.
研究者
相似试验
招募中
不适用
Occult Hepatitis C virus in the liver-transplanted patients received anti-HCV therapyHepatitis C virus infectionJPRN-UMIN000026117Department of Gastroenterology and Hepatology, Nagasaki University Hospital70
招募中
3 期
Transplantation Using Hepatitis C Positive Donors, A Safety TrialLung Transplant InfectionHeart Transplant InfectionKidney Transplant InfectionKidney Pancreas InfectionHepatitis CNCT04017338Jordan Feld40
尚未招募
Unknown
Study on patients with advanced liver cancer who have received chemotherapy and have undergone liver transplantCTRI/2024/03/064473Department of hepatology Gleneagles Hospital Super speciality and transplant centre
已完成
不适用
Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCRHepatitis CESRDNCT02669966University of Florida2
尚未招募
不适用
eukapheresis of healthy volunteer donors for T cell study and TolDC production process validationsNL-OMON52474eids Universitair Medisch Centrum20
